PeptiSystems, a life science company specializing in advanced manufacturing solutions for peptide and oligonucleotide therapeutics, has announced a major growth equity investment from Rubicon Healthcare Partners. This partnership is set to accelerate PeptiSystems’ global expansion and support the delivery of scalable manufacturing solutions to the growing biopharma industry.
Health Technology Insights: Freenome Names Rob Guigley CCO as Exact Sciences Deal Clears
Rubicon Healthcare Partners, a growth-focused investment firm targeting Nordic life science companies, will become the largest shareholder in PeptiSystems. The firm brings significant industry experience and networks to support PeptiSystems’ strategic expansion, helping the company advance its international presence and commercial development.
The investment will allow PeptiSystems to strengthen its organization and accelerate commercialization. The company is expanding its industrial-scale applications and supporting customers in moving toward GMP production of therapeutic peptides and oligonucleotides. This funding builds on PeptiSystems’ growing customer base and strong market momentum.
Health Technology Insights: Headspace and Cigna Launch Enhanced Mental Health Support
Karin Granath, CEO of PeptiSystems, stated, “We are thrilled to welcome Rubicon Healthcare Partners as a shareholder. Their expertise and global reach will help us scale our technology for industrial applications and drive commercialization. This investment shows confidence in our team and strategy.” Ole J. Dahlberg, Managing Partner at Rubicon, said, “PeptiSystems’ innovation, customer focus, and strong leadership make them an ideal partner. We are excited to support their growth strategy.” Mats Johnson, Chairman of the Board of PeptiSystems, added, “Rubicon’s investment will help us expand our unique flow-through technology and accelerate our growth in therapeutic peptide and oligo production.”
Health Technology Insights: AI, Quantum and Biotech Drive Trillion-Dollar Health Shift at GITEX
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
